LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,727,756 | -52.6% | 13,420,242 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $41,600,101 | +42.9% | 13,081,793 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $29,115,634 | -31.0% | 12,337,133 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $42,226,478 | -50.9% | 12,169,014 | +3.8% | 0.00% | -66.7% |
| Q3 2022 | $85,959,000 | +31.8% | 11,727,102 | +17.3% | 0.00% | +50.0% |
| Q2 2022 | $65,198,000 | +65.3% | 9,999,713 | +28.0% | 0.00% | +100.0% |
| Q1 2022 | $39,438,000 | +154.8% | 7,809,490 | +290.6% | 0.00% | – |
| Q4 2021 | $15,476,000 | -26.7% | 1,999,452 | +40.1% | 0.00% | -100.0% |
| Q3 2021 | $21,118,000 | +425.2% | 1,426,897 | +476.3% | 0.00% | – |
| Q2 2021 | $4,021,000 | – | 247,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |